Drawing for FLUZA

USPTO serial 79215322

FLUZA

Reviewed by CopyMark Law Group

Reg. 5516110Status 404
Filing date
Status date
Registration date
Jul 17, 2018
Examiner
SHEN, ELIZABETH S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FLUZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics for treating cancer, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 27, 2018IRRHIRREGULARITY FROM IB EXAMINED BY MPU—
Nov 16, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 16, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 15, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 6, 2018IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Oct 30, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 30, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 17, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 17, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 1, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 11, 2018NPUBNOTICE OF PUBLICATION—
Mar 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2018CNEAEXAMINERS AMENDMENT MAILED—
Mar 22, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 22, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 30, 2018CNSLLETTER OF SUSPENSION MAILED—
Jan 29, 2018CNSLSUSPENSION LETTER WRITTEN—
Jan 9, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 8, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 8, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2017RFNTREFUSAL PROCESSED BY IB—
Sep 12, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 12, 2017RFRRREFUSAL PROCESSED BY MPU—
Sep 9, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 6, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 5, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2017DOCKASSIGNED TO EXAMINER—
Sep 5, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance